ARHC.F logo

Alfresa Holdings OTCPK:ARHC.F Stock Report

Last Price

US$11.87

Market Cap

US$2.5b

7D

0%

1Y

n/a

Updated

24 Jan, 2023

Data

Company Financials +

Alfresa Holdings Corporation

OTCPK:ARHC.F Stock Report

Market Cap: US$2.5b

ARHC.F Stock Overview

Through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. More details

ARHC.F fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance3/6
Financial Health6/6
Dividends4/6

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Alfresa Holdings Corporation Competitors

Price History & Performance

Summary of share price highs, lows and changes for Alfresa Holdings
Historical stock prices
Current Share PriceJP¥11.87
52 Week HighJP¥13.69
52 Week LowJP¥11.87
Beta0.14
1 Month Change0%
3 Month Changen/a
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO-74.47%

Recent News & Updates

Recent updates

Shareholder Returns

ARHC.FUS HealthcareUS Market
7D0%-1.6%-4.1%
1Yn/a-6.7%6.6%

Return vs Industry: Insufficient data to determine how ARHC.F performed against the US Healthcare industry.

Return vs Market: Insufficient data to determine how ARHC.F performed against the US Market.

Price Volatility

Is ARHC.F's price volatile compared to industry and market?
ARHC.F volatility
ARHC.F Average Weekly Movementn/a
Healthcare Industry Average Movement7.1%
Market Average Movement6.4%
10% most volatile stocks in US Market17.3%
10% least volatile stocks in US Market3.4%

Stable Share Price: ARHC.F has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine ARHC.F's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
200311,925Ryuji Arakawawww.alfresa.com

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements, and other products to drug stores and pharmacies.

Alfresa Holdings Corporation Fundamentals Summary

How do Alfresa Holdings's earnings and revenue compare to its market cap?
ARHC.F fundamental statistics
Market capUS$2.52b
Earnings (TTM)US$247.49m
Revenue (TTM)US$20.21b

10.2x

P/E Ratio

0.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ARHC.F income statement (TTM)
RevenueJP¥2.63t
Cost of RevenueJP¥2.44t
Gross ProfitJP¥191.17b
Other ExpensesJP¥158.98b
EarningsJP¥32.20b

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

Feb 07, 2023

Earnings per share (EPS)159.09
Gross Margin7.27%
Net Profit Margin1.22%
Debt/Equity Ratio0.004%

How did ARHC.F perform over the long term?

See historical performance and comparison

Dividends

3.6%

Current Dividend Yield

35%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/01/24 22:35
End of Day Share Price 2022/10/27 00:00
Earnings2022/09/30
Annual Earnings2022/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Alfresa Holdings Corporation is covered by 8 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Toshihide YodaBarclays
Ritsuo WatanabeBofA Global Research
Miyabi YamakitaJefferies LLC